These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
292 related articles for article (PubMed ID: 8842045)
1. In vitro and in vivo evaluation in rabbits of a controlled release 5-fluorouracil subconjunctival implant based on poly(D,L-lactide-co-glycolide). Wang G; Tucker IG; Roberts MS; Hirst LW Pharm Res; 1996 Jul; 13(7):1059-64. PubMed ID: 8842045 [TBL] [Abstract][Full Text] [Related]
2. Antibiotic-loaded plaster of Paris implants coated with poly lactide-co-glycolide as a controlled release delivery system for the treatment of bone infections. Benoit MA; Mousset B; Delloye C; Bouillet R; Gillard J Int Orthop; 1997; 21(6):403-8. PubMed ID: 9498152 [TBL] [Abstract][Full Text] [Related]
3. Antitumor Efficacy and Toxicity of 5-Fluorouracil-Loaded Poly(Lactide Co-glycolide) Pellets. Leelakanok N; Geary SM; Salem AK J Pharm Sci; 2018 Feb; 107(2):690-697. PubMed ID: 29031952 [TBL] [Abstract][Full Text] [Related]
4. Formulation factors for preparing ocular biodegradable delivery system of 5-fluorouracil microparticles. Yeh MK; Tung SM; Lu DW; Chen JL; Chiang CH J Microencapsul; 2001; 18(4):507-19. PubMed ID: 11428679 [TBL] [Abstract][Full Text] [Related]
5. Effective sustained release of 5-FU-loaded PLGA implant for improving therapeutic index of 5-FU in colon tumor. Li L; Li C; Zhou J Int J Pharm; 2018 Oct; 550(1-2):380-387. PubMed ID: 30040972 [TBL] [Abstract][Full Text] [Related]
6. In vitro and in vivo evaluation of an ocular delivery system of 5-fluorouracil microspheres. Chiang CH; Tung SM; Lu DW; Yeh MK J Ocul Pharmacol Ther; 2001 Dec; 17(6):545-53. PubMed ID: 11777178 [TBL] [Abstract][Full Text] [Related]
7. Sustained release microspheres of metoclopramide using poly(D,L-lactide-co-glycolide) copolymers. Elkheshen SA; Radwan MA J Microencapsul; 2000; 17(4):425-35. PubMed ID: 10898083 [TBL] [Abstract][Full Text] [Related]
8. Co-effect of aqueous solubility of drugs and glycolide monomer on in vitro release rates from poly(D,L-lactide-co-glycolide) discs and polymer degradation. Kim JM; Seo KS; Jeong YK; Hai BL; Kim YS; Khang G J Biomater Sci Polym Ed; 2005; 16(8):991-1007. PubMed ID: 16128233 [TBL] [Abstract][Full Text] [Related]
9. 5-FU loaded pHEMA drainage implants for glaucoma-filtering surgery: device design and in vitro release kinetics. Gökce M; Akata RF; Kiremitçi-Gümüşderelioğlu M Biomaterials; 1996 May; 17(9):941-9. PubMed ID: 8718940 [TBL] [Abstract][Full Text] [Related]
10. Fabrication and Use of Poly(d,l-lactide-co-glycolide)-Based Formulations Designed for Modified Release of 5-Fluorouracil. Leelakanok N; Geary S; Salem A J Pharm Sci; 2018 Feb; 107(2):513-528. PubMed ID: 29045885 [TBL] [Abstract][Full Text] [Related]
11. 5-Fluorouracil plasma levels and biodegradation of subcutaneously injected drug-loaded microspheres prepared by spray-drying poly(D,L-lactide) and poly(D,L-lactide-co-glycolide) polymers. Sastre RL; Olmo R; Teijón C; Muñíz E; Teijón JM; Blanco MD Int J Pharm; 2007 Jun; 338(1-2):180-90. PubMed ID: 17336474 [TBL] [Abstract][Full Text] [Related]
12. Membrane-encased polymer millirods for sustained release of 5-fluorouracil. Qian F; Nasongkla N; Gao J J Biomed Mater Res; 2002 Aug; 61(2):203-11. PubMed ID: 12007200 [TBL] [Abstract][Full Text] [Related]
13. A poly(ortho ester) designed for combined ocular delivery of dexamethasone sodium phosphate and 5-fluorouracil: subconjunctival tolerance and in vitro release. Zignani M; Einmahl S; Baeyens V; Varesio E; Veuthey JL; Anderson J; Heller J; Tabatabay C; Gurny R Eur J Pharm Biopharm; 2000 Sep; 50(2):251-5. PubMed ID: 10962235 [TBL] [Abstract][Full Text] [Related]
14. Controlled delivery of ganciclovir to the retina with drug-loaded Poly(d,L-lactide-co-glycolide) (PLGA) microspheres dispersed in PLGA-PEG-PLGA Gel: a novel intravitreal delivery system for the treatment of cytomegalovirus retinitis. Duvvuri S; Janoria KG; Pal D; Mitra AK J Ocul Pharmacol Ther; 2007 Jun; 23(3):264-74. PubMed ID: 17593010 [TBL] [Abstract][Full Text] [Related]
15. Degradation behaviour in vitro for poly(D,L-lactide-co-glycolide) as drug carrier. Lee JS; Chae GS; Kim MS; Cho SH; Lee HB; Khang G Biomed Mater Eng; 2004; 14(2):185-92. PubMed ID: 15156109 [TBL] [Abstract][Full Text] [Related]
16. Subconjunctival sustained release 5-fluorouracil for glaucoma filtration surgery. Cui LJ; Sun NX; Li XH; Huang J; Yang JG Acta Pharmacol Sin; 2008 Sep; 29(9):1021-8. PubMed ID: 18718170 [TBL] [Abstract][Full Text] [Related]
17. Depot drug delivery system for 5-fluorouracil after filtration surgery in the rabbit. Trope GE; Cheng YL; Sheardown H; Liu GS; Menon IA; Heathcote JG; Rootman DS; Chiu WJ; Gould L Can J Ophthalmol; 1994 Dec; 29(6):263-7. PubMed ID: 7834564 [TBL] [Abstract][Full Text] [Related]
18. Wound modulation after trabeculectomy by different formulations of antimetabolites in rabbits. Lu DW; Chang CJ; Chiang CH; Yeh MK; Chou PI J Ocul Pharmacol Ther; 2000 Dec; 16(6):529-38. PubMed ID: 11132900 [TBL] [Abstract][Full Text] [Related]
19. Co-delivery of an antisense oligonucleotide and 5-fluorouracil using sustained release poly (lactide-co-glycolide) microsphere formulations for potential combination therapy in cancer. Hussain M; Beale G; Hughes M; Akhtar S Int J Pharm; 2002 Mar; 234(1-2):129-38. PubMed ID: 11839444 [TBL] [Abstract][Full Text] [Related]
20. The effects of 5-fluorouracil on ocular tissues in vitro and in vivo after controlled release from a multifunctional implant. Huhtala A; Rönkkö S; Teräsvirta M; Puustjärvi T; Sihvola R; Vehanen K; Laukkanen A; Anttila J; Urtti A; Pohjonen T; Uusitalo H Invest Ophthalmol Vis Sci; 2009 May; 50(5):2216-23. PubMed ID: 19136700 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]